Physicochemical and pharmacokinetic properties of COMT inhibitors

被引:1
|
作者
Forsberg, Markus [1 ]
机构
[1] Univ Kuopio, Dept Pharmacol & Toxicol, FIN-70211 Kuopio, Finland
关键词
D O I
10.1016/j.ejps.2008.02.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S8 / S8
页数:1
相关论文
共 50 条
  • [21] RELATIONSHIP BETWEEN PHARMACOKINETIC PROPERTIES AND EFFICACY OF ACE INHIBITORS
    RETTIG, R
    GOHLKE, P
    UNGER, T
    ZEITSCHRIFT FUR KARDIOLOGIE, 1991, 80 : 16 - 20
  • [22] SYNTHESIS OF HYDROXYTYROSOL NITRODERIVATIVES AS COMT INHIBITORS
    Gallardo-Morillo, E.
    Trujillo, M.
    Santiago, M.
    Madrona, A.
    Palma, R.
    Espartero, J. L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 48 - 48
  • [23] Comparative Physicochemical and Pharmacokinetic Properties of Quetiapine and Its Active Metabolite Norquetiapine
    Kim, Dong-Wook
    Weon, Kwon-Yeon
    Hong, Eon-Pyo
    Chung, Eun Kyoung
    Lee, Kyung-Tae
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 64 (11) : 1546 - 1554
  • [24] COMT inhibitors in Parkinson's disease
    Rivest, J
    Barclay, CL
    Suchowersky, O
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 : S34 - S38
  • [25] Simultaneously improving the physicochemical and pharmacokinetic properties of vemurafenib through cocrystallization strategy
    Huang, Guan-Lan
    Yang, Ling
    Ren, Bo-Ying
    Lv, Xin-Yue
    Song, Ling-Yi
    Dai, Xia-Lin
    Chen, Jia-Mei
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 70
  • [26] Amelioration of physicochemical, pharmaceutical, and pharmacokinetic properties of lornoxicam by cocrystallization with a novel coformer
    Fatima, Kanwal
    Bukhari, Nadeem Irfan
    Latif, Sumera
    Afzal, Hafsa
    Hussain, Amjad
    Shamim, Rahat
    Abbas, Nasir
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2021, 47 (03) : 498 - 508
  • [27] EFFECT OF PHYSICOCHEMICAL AND PHARMACOKINETIC PROPERTIES OF BARBITURATES ON INDUCTION OF DRUG-METABOLISM
    PELKONEN, O
    KARKI, NT
    CHEMICO-BIOLOGICAL INTERACTIONS, 1973, 7 (02) : 93 - 99
  • [28] Assessment of the Physicochemical Properties and Stability for Pharmacokinetic Prediction of Pyrazinoic Acid Derivatives
    Franchin, Taisa Busaranho
    Ulian Silva, Bruna Cristina
    DeGrandis, Rone Aparecido
    Correa, Michelle Fidelis
    Simoes de Queiroz Aranha, Cecilia Maria
    Fernandes, Joao Paulo S.
    Campos, Michel Leandro
    Peccinini, Rosangela Goncalves
    CURRENT DRUG METABOLISM, 2020, 21 (09) : 714 - 721
  • [29] Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation
    Thomas, SM
    Grandis, JR
    CANCER TREATMENT REVIEWS, 2004, 30 (03) : 255 - 268
  • [30] Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties
    Bruncko, M
    McClellan, WJ
    Wendt, MD
    Sauer, DR
    Geyer, A
    Dalton, CR
    Kaminski, MA
    Weitzberg, M
    Gong, J
    Dellaria, JF
    Mantei, R
    Zhao, X
    Nienaber, VL
    Stewart, K
    Klinghofer, V
    Bouska, J
    Rockway, TW
    Giranda, VL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (01) : 93 - 98